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LPS promotes Th2 dependent 
sensitisation leading to anaphylaxis 
in a Pru p 3 mouse model
Maria J. Rodriguez1,*, Ana Aranda1,*, Tahia D. Fernandez1, Nuria Cubells-Baeza2, 
Maria J. Torres3, Francisca Gomez3, Francisca Palomares1, James R. Perkins1, Javier Rojo4, 
Araceli Diaz-Perales2,* & Cristobalina Mayorga1,3,*
Pru p 3 is the major peach allergen in the Mediterranean area. It frequently elicits severe reactions, 
limiting its study in humans, raising the need for animal models to investigate the immunological 
mechanisms involved. However, no anaphylaxis model exists for Pru p 3. We aimed to develop a model 
of peach anaphylaxis by sensitising mice with Pru p 3 in combination with lipopolysaccharide (LPS) as 
an adjuvant. Four groups of mice were sensitised intranasally: untreated; treated with Pru p 3; treated 
with LPS; treated with Pru p 3 + LPS. After sensitisation mice were intraperitoneally challenged with 
Pru p 3 and in vivo and in vitro parameters were evaluated. Only mice in the Pru p 3 + LPS group showed 
anaphylaxis symptoms, including a decrease in temperature. Determination of in vitro parameters 
showed a Th2 response with an increase of Pru p 3-specific IgE and IgG1. Moreover, at the cellular level, 
we found increased levels of IgE and IgG1 secreting Pru p 3-specific cells and a proliferative CD4+ T-cell 
response. These results demonstrate that Pru p 3-specific anaphylaxis can be generated after nasal 
sensitisation to Pru p 3 in combination with LPS. This is a promising model for evaluating food allergy 
immunotherapies.
Food allergic reactions are an increasing worldwide problem, with important effects on health systems and the 
quality of life of individuals. Plant allergens are the most frequent elicitors of food allergy in adults1,2. Only a small 
number of protein families contain allergens3, one of the most important being lipid transfer proteins (LTP) from 
the Rosaceae family, which includes apple and peach. Allergens from this family are frequently involved in allergic 
reactions to plant-derived foods4,5.
The immunological mechanisms underlying food allergy are characterised by the induction of specific Th2 
cells and production of specific IgE antibodies to food proteins6. Animal models have been used to improve our 
understanding of the immunological and pathophysiological mechanisms involved in the development of food 
allergy6–8 and to assess the modulation of the immune response9. The mouse immune system is well-characterised 
and it represents an excellent model to study an immune reaction in its full complexity in vivo. Various mouse 
models that mimic allergic responses involving specific IgE production have been developed using antigens such 
as ovalbumin10, as well as food allergens such as milk11, wheat (gliadin)12, peanut13 and tree nuts14. The allergen 
administration route is very important for sensitisation in food allergen models and oral administration is often 
seen as the logical choice15. However, this route may in fact have a low sensitising potential for inducing IgE 
antibody responses, probably due to the fact that the gastrointestinal tract has an important tolerogenic role16–18. 
Moreover, clinical studies have suggested that exposure to allergens through the skin or the respiratory tract 
might also play a role in food sensitisation19,20.
LTPs are panallergens with high stability to heat, pH and enzymatic digestion, and frequently associated with 
systemic and severe symptoms like anaphylaxis21–23. Pru p 3 is a member of the LTP family and the major peach 
allergen in the Mediterranean area21,24. The high sensitisation to Pru p 3, its cross-reactivity with other foods and 
pollens and its frequent involvement in severe reactions make it difficult to investigate the mechanisms underly-
ing peach allergy in humans, although several studies have been performed looking into the role of sIgE and its 
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influence on reaction severity25 and cross-reactivity with other plants21,24,26. Nevertheless, there is a clear need to 
develop approaches for its study, such as experimental models. However, although Pru p 3 sensitised mouse mod-
els with IgE production have been developed27, no anaphylaxis model demonstrated by in vivo parameters has yet 
been achieved. Some authors have demonstrated that the intrinsic adjuvant activity provided by associated lipids 
could underlie the allergenicity of some proteins20,28. Thus, the use of adjuvants may enhance allergic sensitisation 
in animal models. In this sense, lipopolysaccharide (LPS), a bacterial component, represents a potential candidate 
since it has been shown to modulate the immune response by interacting with toll-like receptor 4 (TLR4). LPS 
has been shown to be able to induce both Th1 and Th2 responses depending on dosage, with low levels of LPS 
facilitating a Th2 response and allergic reaction29.
In this study we aimed to develop a mouse model of LTP peach anaphylaxis using Pru p 3 as sensitiser. This 
was achieved through the administration of low doses of LPS as adjuvant. The allergic response after challenge 
with Pru p 3 was characterised based on in vivo (temperature and symptom scores) and in vitro tests (deter-
mination of Pru p 3 specific immunoglobulins by ELISA and cellular responses in splenic cells by either 
immunoglobulins-secreting cell quantification, T-cell proliferation and cytokine production).
Results
Pru p 3 together with LPS induced anaphylaxis. In order to produce a mouse model of food ana-
phylaxis to peach, we sensitised mice intranasally with Pru p 3 (20 μ g), with LPS (20 ng) or with Pru p 3 in 
combination with LPS (Pru p 3 + LPS) once a week for six weeks (Fig. 1). We used intranasal routes instead of 
oral for several reasons: (i) dose of protein needed13, (ii) the intrinsic tolerogenic capacity of the gastrointestinal 
route16,17,30 and (iii) the capacity of Pru p 3 to sensitise patients through inhalation31–36. One week after the final 
sensitisation, all mouse groups (including untreated mice) were challenged with Pru p 3 (100 μ g) by intraperi-
toneal injection. Mice sensitised with Pru p 3 + LPS, but not those sensitised with either Pru p 3 or LPS, devel-
oped systemic anaphylaxis (Fig. 2a), consisting of a significant decrease in body temperature (p = 0.0059) and 
Figure 1. Schematic of the experimental procedures. At day 0, blood samples were collected from each 
mouse. Sensitisation were performed intranasally once a week for 6 weeks (on days 0, 7, 14, 21, 28, 35) with the 
different treatments depending on the group. At day 42 mice were challenged with one intraperitoneal dose of 
Pru p 3 (100 μ g per mouse), following which in vivo parameters were measured. After this, the blood and spleen 
were collected from each mouse.
Figure 2. Measurement of in vivo parameters after challenge with Pru p 3. The appearance of systemic 
anaphylactic symptoms were evaluated 30–40 minutes after challenge with Pru p 3 measuring: (a) Changes 
in body temperature (°C) determining the rectal temperature before (Basal) and 30 minutes after challenge 
(Challenged). Statistical analysis were performed using the Wilcoxon test for related samples and significance 
was set at p < 0.05. (b) Clinical score, according to a scoring system: 0: no symptoms; 1: scratching and rubbing 
around the nose and head; 2: puffiness around the eyes and mouth, diarrhoea, ‘pilar erecti’, reduced activity and/
or decreased activity with increased respiratory rate; 3: wheezing, laboured respiration, and cyanosis around 
the mouth and the tail; 4: no activity after prodding or tremor and convulsion and 5: death. Symbols represent 
individual mice in each group: White circles for untreated group (N = 10); grey squares for Pru p 3 treated 
group (N = 10); grey triangles for LPS treated group (N = 10) and black squares for Pru p 3 plus LPS treated 
group (N = 10). Statistical analysis were performed with Mann-Whitney U test for non-related samples and 
significance was set at p < 0.05.
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appearance of severe clinical symptoms (Fig. 2b), demonstrated by inactivity, isolation and increased respiratory 
rate. We did not detect any changes in the body temperature or systemic symptoms of anaphylaxis in the different 
control groups (untreated, sensitised with Pru p 3 or sensitised with LPS).
Pru p 3 + LPS-exposed mice produced specific IgE and IgG1 antibodies. To further explore the 
relationship between the in vivo symptoms of anaphylaxis and the humoral response, serum levels of Pru p 
3-specific IgE and IgG1 were measured by ELISA (Fig. 3a,b). Pru p 3 + LPS sensitised mice developed an anaphy-
lactic response with a significant increase in Pru p 3-specific IgE (p = 0.0156) and IgG1 (p = 0.039) production 
compared to basal. Data also showed a significant increase of Pru p 3-specific IgE levels (p = 0.0273) in mice 
sensitised with Pru p 3, although those Ievels were lower than Pru p 3 + LPS sensitised mice, which developed 
symptoms of an anaphylactic response. No significant changes in Pru p 3-specific IgG1 were observed in mice 
sensitised only with Pru p 3.
A correlation was found between anaphylactic symptoms and the change in specific IgE levels after the immu-
nisation period, with more severe symptoms in those mice with higher levels of IgE antibodies to Pru p 3.
Pru p 3-specific antibody secreting cells in an ELISpot assay. We assessed the number of IgE and 
IgG1 secreting cells after Pru p 3 stimulation by ELISpot assay. Data showed a significant increase in the number 
of Pru p 3-specific IgE secreting cells in mice sensitised with Pru p 3 + LPS compared to untreated, treated with 
Pru p 3 only, and with LPS only (p = 0.0002, p = 0.0025 and p = 0.002, respectively). Moreover, the number of 
Pru p 3-specific IgE secreting cells was significantly higher in mice sensitised with Pru p 3 only compared to the 
untreated group (p = 0.0002).
Regarding the IgG1 secreting cells, we observed a significant increase only in mice sensitised with Pru p 
3 + LPS compared to untreated, treated with Pru p 3 and with LPS (p < 0.0001 for all) (Fig. 4).
Splenocytes from Pru p 3 + LPS-exposed mice show a specific proliferative response. The gen-
eration of IgE antibodies resulting in clinical food allergy could potentially be driven by Th2 cell subsets. We 
determined the effects of Pru p 3 + LPS on the immunological response in terms of the functional consequences 
on T cell priming. Splenocytes of mice from the different groups were isolated following challenge. We then ana-
lysed the proliferative response of CD4+ and CD8+ T cell subpopulations following 4 days of incubation with Pru 
p 3. A significant increase in the proliferative index (PI) was only detected in the CD4+ T cell subpopulation, and 
only in the Pru p 3 + LPS group compared to untreated (p = 0.0068), Pru p 3 (p = 0.0001) and LPS (p = 0.0004) 
groups. It is important to note that, despite the presence of LPS, no proliferative response of CD8+ T cells was 
found. These results indicate that, although LPS is usually related to a Th1 response in which the CD8+ T cell 
subpopulation is involved, the sensitisation of mice with low LPS doses in the presence of Pru p 3 leads to a Th2 
response (Fig. 5a).
In order to characterise the proliferative response at the molecular level, we evaluated the production of dif-
ferent cytokines: IL-10, indicative of the regulatory response; IL-4, indicative of the Th2 response; and IFN-γ 
indicative of the Th1 response. These cytokines were quantified in the culture supernatant obtained during the 
splenocyte proliferative response to Pru p 3 by ELISA (Fig. 5b). Data showed a significant increase in production 
of IL-4 and IFN-γ in mice immunised with Pru p 3 + LPS compared to untreated, treated with Pru p 3 only, and 
LPS only (IL-4: p = 0.0453, p = 0.0333 and p = 0.0221 respectively; IFN-γ : p = 0.0423, p = 0.0423 and p = 0.0251, 
respectively). Moreover, the group of mice immunised with Pru p 3 + LPS was the only one with no IL10 produc-
tion (Fig. 5b). Interestingly, an IL-4-driven increase in splenocytes of the group sensitised only with Pru p 3 was 
not observed, suggesting that the mechanism involved in the induction of Th2 responses is dependent on Pru p 
3 in the presence of LPS.
Discussion
The development of Th2 cells is believed to be a critical step in the underlying mechanisms of food allergy. 
However, the factors involved in the triggering of food allergen-specific Th2 activation remain poorly under-
stood. Pru p 3 is one of the most important plant food panallergens in the Mediterranean area and can cause 
Figure 3. Evolution of serum level of Pru p 3-specific IgE and IgG1. Bars represent the mean level of Pru p 
3-specific antibodies (a) IgE and (b) IgG1 production before (white bar) and after sensitisation (grey bar) in 
different groups were analysed by ELISA. Serum samples were diluted 1:8 for IgE and 1:50 for IgG1. Statistical 
analysis were performed using the Wilcoxon test for related samples and significance was set at p < 0.05.
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life-threatening reactions21,24,26. The severity of the reactions limits the use of human studies and raises the need 
for animal models to assess the immunological mechanisms. However, although mouse models with Pru p 3 IgE 
production have been generated27, no comprehensive anaphylaxis model, confirmed by both in vivo and in vitro 
parameters, exists. The development of such a model is critical for many applications, for example to test the 
safety and potential benefits of immunotherapy for food allergens.
The choice of administration route is critical for the generation of an allergy model. In the case of peach 
allergy, although it has been associated with the oral and gastrointestinal routes, some authors found a limited IgE 
antibody response that could be the consequence of the tolerance mechanisms associated with these routes16,17. 
Moreover, food allergic reactions may also develop following airborne sensitisation and/or challenge, as shown 
by Pru p 3 which can sensitise patients through both the oral and inhalational routes31–36.
Some data indicated that the tendency of some proteins to trigger the adaptive immune responses towards 
a Th2 pattern is due to their ability to promote TLR4 signalling28. Moreover, the allergenicity of some proteins 
for inducing a Th2 response could be enhanced in the presence of adjuvants37,38. In fact, it is thought that the 
exposure of the mucosal immune system to bacterial compounds like LPS alongside food antigens can lead to 
food antigen sensitisation and allergy. These bacterial products might promote allergic sensitisation via TLR4 
signalling39,40. Previous studies have shown that depending on the concentration, LPS can modulate the response 
towards a Th1 pattern at high concentrations or enhance the induction of a Th2 response when using low levels 
(< 100 ng)37,41.
In the present study, we have demonstrated that the Pru p 3-specific anaphylactic response can be generated 
after nasal sensitisation to Pru p 3 in combination with LPS as adjuvant. This anaphylactic response was demon-
strated in vivo by a significant temperature drop alongside the appearance of objective symptoms of anaphy-
laxis in the group of Pru p 3 + LPS immunised mice. This anaphylactic model leads to higher levels of humoral 
Th2-mediated immunoglobulins IgE and IgG1 which agree with results observed in sensitisation models for 
other allergens27, obtained using a different administration route (intraperitoneally) and adjuvant (aluminium 
hydroxide).
It is interesting to note that although an increase of Pru p 3-specific IgE was observed in both Pru p 3 and Pru 
p 3 + LPS immunised mice, a significantly higher level was observed in the latter, suggesting a key role of sIgE in 
the clinical response. This finding potentially indicates that sIgE levels can be a biomarker for differentiating sen-
sitisation from real allergy as has been proposed by other authors42,43. Moreover the anaphylactic group, treated 
with Pru p 3 + LPS, also showed a significant increase of Pru p 3 specific IgG1 that was not observed in mice sen-
sitised with Pru p 3 only. It is tempting to speculate that high levels of sIgE together with the increase of sIgG1 may 
be related with the appearance of anaphylactic symptoms as has been demonstrated in patients with anaphylaxis 
to peach and other allergens25,44,45.
Figure 4. Pru p 3 specific antibody secreting cells. Specific IgE and IgG1 secreting cells were evaluated by 
ELISpot assay. The number of Ig secreting cells was determined by counting the formed spots using an ELISpot 
reader. Dots represent the number of (a) IgE and (b) IgG1 secreting splenocytes from individual mice. Symbols 
representing different groups of mice: White circles for untreated group (N = 10); grey squares for Pru p 3 treated 
group (N = 10); grey triangles for LPS treated group (N = 10) and black squares for Pru p 3 plus LPS treated group 
(N = 10). Statistical analysis were performed with Mann-Whitney U test for unrelated samples and significance 
was set at p < 0.05. Horizontal lines represent the mean values for each group. (c) Representative sIgE and sIgG1 
ELISpot wells from Pru p 3-stimulated splenocytes from untreated mice and treated with Pru p 3, LPS and Pru p 
3 + LPS. The numbers in the lower right corners indicate counted spots.
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The use of some adjuvants may compromise the specific response to the allergen, and moreover, the type of 
response. LPS has a role in the innate immune system in the development of a Th1 response46 in which CD8+ T 
cells are involved. However, in our model the use of LPS in combination with Pru p 3 not only induces the spe-
cific antibody response to Pru p 3 but also leads to a Th2 response pattern, confirmed by the increase of specific 
IgE and IgG1 antibodies, of IgE and IgG1 secreting cells, and increased IL4 levels. Moreover, the analysis of the 
proliferating cell phenotype showed that the combination of Pru p 3 + LPS induced Pru p 3-specific activation of 
CD4+ T-lymphocytes and no proliferative response of CD8+ T cells was found. Additionally, no proliferation to 
Pru p 3 was found in mice sensitised with LPS alone.
Our results suggest that Pru p 3 challenge of Pru p 3 + LPS mice sensitised by the nasal route can lead to 
anaphylactic responses. The mechanism by which Pru p 3 + LPS exposure can elicit an adaptive response, lead-
ing to the induction of IgE and CD4+ T cells is not clear but may relate to features of the resident dendritic cells 
within each site, such as differential expression of innate receptors. Additionally, previous reports have shown 
that Th2-type responses induced in the gastrointestinal tract can influence immunophysiological responses in 
distant, non-inflamed mucosal tissue and regulate airway responsiveness47,48. The priming of naïve T cells to 
become protein specific Th2 cells requires the activation of the innate immune system to be provoked by LPS29,49 
causing IgE synthesis. The proliferative response of CD4+ T cells in the presence of Pru p 3 demonstrates that the 
results are mediated by the adaptive immune response with T cells specific to the allergen and not the early innate 
immune response to LPS.
Our results suggest that LPS alongside Pru p 3 can stimulate immune cells in the upper respiratory tract and 
trigger a state of systemic pro-inflammation. To our knowledge, this is the first effective model of anaphylaxis 
caused by Pru p 3. The use of these anaphylactic mice shows great potential for testing and developing novel 
immunotherapy approaches for food allergens, with potential applications to other allergies.
Methods
Mice sensitisation. Female Balb/c mice (4–5 weeks old), as used in other studies50,51, were used (Janvier Lab, 
Saint-Berthevin Cedex, France).
All experimental animal procedures conformed to international standards of animal welfare and were 
approved by the Animal Experimentation Ethics Committee of BIONAND, Malaga, Spain. Mice were divided 
Figure 5. (a) Proliferative response of splenocytes from different groups. PI of CD4+ (left) and CD8+ 
subpopulations (right), after 4 days of Pru p 3 stimulation in different sensitised mice groups. PI were measured 
as the ratio of % CD4+CFSEdim or CD8+CFSEdim cells in stimulated samples/% CD4+CFSEdim or CD8+CFSEdim 
in non-stimulated samples for CD4+ and CD8+ respectively. Symbols represent individual mice in each group: 
White circles for untreated group (N = 10); grey squares for Pru p 3 treated group (N = 10); grey triangles for 
LPS treated group (N = 10) and black squares for Pru p 3 plus LPS treated group (N = 10). Statistical analyses 
were performed using the Mann-Whitney U test for non-related samples and significance was set at p < 0.05. 
Dotted line shows established cut-off point (PI = 2) for a positive test result. (b) Cytokine production during 
the proliferative response. The cytokines were quantified by ELISA in the culture supernatant obtained during 
the splenocyte proliferative response to Pru p 3. Bars represent the mean of concentration in pg/mL and s.d. of 
IL-10, IL-4 and IFN-γ secretion (i, ii and iii, respectively) in splenocytes derived from different groups of mice 
after re-stimulation of spleen cells with Pru p 3. White bars for the untreated group; light grey bars for the Pru 
p 3 treated group; dark grey bars for the LPS treated group and black bars for the Pru p 3 + LPS treated group. 
Statistical analysis were performed using the Mann-Whitney U test for unrelated samples and significance was 
set at p < 0.05.
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into 4 groups (N = 10 per group): (1) Untreated; (2) Treated with Pru p 3; (3) Treated with LPS; (4) Treated with 
both Pru p 3 and LPS (Pru p 3 + LPS). Mice were anaesthetised with inhaled Forane (Abbott Laboratories Ltd., 
Kent, UK) and sensitised with six nasal administrations (12 μ l) of 20 μ g of purified peach protein, natural Pru p 3 
(Bial Laboratory, Zamudio, Spain) and/or 20 ng of LPS (InvivoGen, San Diego, CA), depending on the group, 
according to published studies38, on days 0, 7, 14, 21, 28 and 35 (Fig. 1). Mice were challenged 1 week after the last 
immunisation (day 42) by receiving one intraperitoneal dose of Pru p 3 (100 μ g per mouse) (Fig. 1).
Assessment of anaphylactic responses. The appearance of systemic anaphylaxis was evaluated 
30–40 minutes after challenge (day 42) in their habitual living environment that is their own cage, by measuring 
drop in body temperature with a rectal probe, and by assessing physical and behavioural symptoms.
Symptoms were established according to a scoring system13, 0: no symptoms; 1: scratching and rubbing 
around the nose and head; 2: puffiness around the eyes and mouth, diarrhoea, ‘pilar erecti’, reduced activity and/
or decreased activity with increased respiratory rate; 3: wheezing, laboured respiration, and cyanosis around the 
mouth and the tail; 4: no activity after prodding or tremor and convulsion and 5: death. Mice were bled from 
the retro-orbital plexus on day 0 (Basal) and 42 (after challenge), and sera were stored at − 20 °C for humoral 
studies. After the challenge and in vivo evaluation, mice were sacrificed by cervical dislocation and the spleen was 
removed aseptically and teased to prepare a single-cell suspension for cellular analysis.
Humoral response. Pru p 3-specific serum antibody (IgE and IgG1) was measured at 0 and 42 days in mice 
sera by ELISA. Briefly, 96-well microtiter polystyrene ELISA plates (Corning, NY, USA) were coated with 5 μ g/ml 
of Pru p 3 in coating buffer, pH 9.6, overnight at 4 °C. Fifty μ l of serum was added in duplicates (diluted 1:8 for 
IgE and 1:50 for IgG1) and incubated overnight at 4 °C. After washing, the plates were incubated with biotinylated 
labelled goat anti-mouse IgE at 1:1000 (BD Pharmingen, San Diego, CA, USA) and goat anti-mouse IgG1 at a 
1:3000 dilution (BD Pharmingen) for 1 hour at room temperature. After washing, avidin-HRP (BD Pharmingen) 
solution at 1:5000 for IgE and 1:1000 for IgG1 was added and samples were incubated for 30 minutes at room tem-
perature. Then, 50 μ l of ready to use TMB substrate (BD Pharmingen) was added and incubated for 10 minutes in 
dark condition. The enzymatic reaction was stopped with 50 μ l of H2SO4(2 N) and absorbance was read at 450 nm. 
The ELISA results were expressed in optical density.
ELISpot Assay. The number of antibody-secreting cells was measured by a modified ELISpot assay origi-
nally described by Czerkinsky et al.52. Briefly, ELISpot Multiscreen HTS plates (96 wells) (Millipore, Darmstadt, 
Germany) were coated overnight at 4 °C with Pru p 3 at 5 μ g/mL. Plates were blocked for one hour at 37 °C 
with blocking solution (Sigma-Aldrich, St. Louis, MO) and a total of 1.5 × 105 cells were seeded and incubated 
for 48 hours. After washing, 50 μ l of alkaline phosphatase labelled- anti IgE at 1:1000, anti-IgG1 at 1:4000 and 
anti-IgM (positive control) at 1:3000 (SouthernBiotech) were added to each well and incubated overnight at 
4 °C. After washing, 100 μ l of ready to use solution of previously filtered NBT-BCIP (Sigma-Aldrich) was 
added. The colorimetric reaction was allowed to proceed until spots were clearly evident on positive-control, 
total-IgM-capture wells (15 minutes). The reagent and plate backing material were removed, and reactions were 
quenched with distilled water. The number of Ig secreting cells was determined by counting the formed spots 
using an ELISpot Bioreader(R) 6000 (BioSys, Karben, Germany).
Lymphocyte proliferation. Proliferation analysis was performed by flow cytometry. Spleen cells were har-
vested and labelled with 5,6-carboxyfluorescein diacetate N-succinimidyl ester (CFSE) using CellTrace™ CFSE 
Cell Proliferation Kit (Life Technologies, Invitrogen, USA) following the manufacturer’s instructions. After this, 
2 × 106 cells/well were seeded in 24-well plates (Nunc, Roskilde, Denmark) in complete medium (RPMI 1640 
(Lonza, BioWhittaker, Verviers, Belgium) supplemented with 2 mM of L-Glutamine (BioWhittaker, Pittsburgh, 
PA), gentamicin (5 μ g/uL) (Normon, Madrid, Spain), streptomycin (50 ng/mL) and 10% fetal bovine serum 
(BioWhittaker)). Cells were incubated in absence (negative control) or presence of Pru p 3 at 5 μ g/mL for 4 days 
at 37 °C and 5% of CO2.
After this, the cells were harvested and stained with specific fluorochrome-conjugated moAbs, antiCD4-PE 
and antiCD8-PE-Cy7A (BD Pharmingen) and phenotyped with a BD™ FACSCanto II flow cytometer and ana-
lysed using FlowJo® software (Tree Star, Inc. USA). Results were expressed as proliferation index (PI) for CD4+ 
or CD8+ measured as the ratio: %CD4+CFSEdim or %CD8+CFSEdim in stimulated sample/%CD4+CFSEdim or 
%CD8+CFSEdim in non-stimulated sample. Proliferative response was considered positive when the PI was higher 
than 2.
Cytokine production. IL-10, IL-4 and IFN-γ were determined from 72 h spleen cell culture supernatants 
described above using sandwich ELISA kits (BD Biosciences Pharmingen) according to the manufacturer’s 
instructions. The results were expressed as pg/ml.
Statistical analysis. Data were presented as individual values and mean with s.d. values. Quantitative unre-
lated variables were analysed using the Mann-Whitney U test, Kruskal-Wallis test and X2-test. Comparisons 
of related samples were carried out by Wilcoxon test. Correlation analysis was performed using Pearson’s test. 
P-values lower than 0.05 were considered statistically significant.
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